| Primary |
| Type 2 Diabetes Mellitus |
36.6% |
| Diabetes Mellitus Non-insulin-dependent |
31.5% |
| Diabetes Mellitus |
10.1% |
| Drug Use For Unknown Indication |
5.8% |
| Hypertension |
3.9% |
| Blood Cholesterol |
1.4% |
| Blood Pressure |
1.3% |
| Cardiac Disorder |
1.2% |
| Product Used For Unknown Indication |
1.1% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Depression |
0.8% |
| Prophylaxis |
0.7% |
| Pain |
0.7% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Blood Pressure Increased |
0.6% |
| Glucose Tolerance Impaired |
0.5% |
| Weight Decreased |
0.4% |
| Asthma |
0.4% |
| Hypothyroidism |
0.4% |
|
| Weight Decreased |
39.8% |
| Blood Glucose Increased |
13.8% |
| Nausea |
10.2% |
| Vomiting |
7.8% |
| Pancreatitis |
5.7% |
| Weight Increased |
3.5% |
| Tremor |
2.6% |
| Pancreatitis Acute |
2.0% |
| Incorrect Dose Administered |
1.9% |
| Injection Site Pain |
1.8% |
| Drug Effect Decreased |
1.6% |
| Drug Ineffective |
1.4% |
| Injection Site Haemorrhage |
1.3% |
| Malaise |
1.2% |
| Medication Error |
1.1% |
| Injection Site Bruising |
0.9% |
| Renal Failure |
0.9% |
| Pancreatic Carcinoma |
0.9% |
| Somnolence |
0.8% |
| Off Label Use |
0.8% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
46.5% |
| Diabetes Mellitus |
10.3% |
| Hypertension |
8.4% |
| Diabetes Mellitus Non-insulin-dependent |
4.7% |
| Blood Cholesterol |
3.7% |
| Blood Pressure |
3.7% |
| Cardiac Disorder |
3.6% |
| Product Used For Unknown Indication |
2.5% |
| Blood Cholesterol Increased |
2.3% |
| Prophylaxis |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Depression |
1.7% |
| Blood Pressure Increased |
1.4% |
| Pain |
1.3% |
| Asthma |
1.2% |
| Hypothyroidism |
1.1% |
| Anxiety |
1.0% |
| Thyroid Disorder |
0.9% |
| Supplementation Therapy |
0.9% |
| Osteoarthritis |
0.8% |
|
| Weight Decreased |
51.0% |
| Vomiting |
10.4% |
| Nausea |
6.8% |
| Pancreatitis |
6.6% |
| Weight Increased |
5.7% |
| Blood Glucose Increased |
2.7% |
| Tremor |
2.5% |
| Pancreatitis Acute |
2.0% |
| Off Label Use |
1.8% |
| Urinary Tract Infection |
1.2% |
| Pancreatic Carcinoma |
1.1% |
| Weight Fluctuation |
1.1% |
| Renal Failure Acute |
1.0% |
| Visual Acuity Reduced |
0.9% |
| Myocardial Infarction |
0.9% |
| White Blood Cell Count Increased |
0.9% |
| Pain |
0.8% |
| Thyroid Cancer |
0.8% |
| Renal Failure |
0.8% |
| Vision Blurred |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Drug Use For Unknown Indication |
18.1% |
| Diabetes Mellitus |
15.7% |
| Type 2 Diabetes Mellitus |
9.7% |
| Hypertension |
6.4% |
| Blood Cholesterol Increased |
3.3% |
| Depression |
2.6% |
| Pain |
1.9% |
| Rheumatoid Arthritis |
1.7% |
| Anxiety |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Asthma |
1.3% |
| Blood Cholesterol |
1.2% |
| Blood Pressure |
1.1% |
| Psoriasis |
1.1% |
| Blood Triglycerides Increased |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Prophylaxis |
1.0% |
| Diabetes Mellitus Non-insulin-dependent |
1.0% |
| High Density Lipoprotein Decreased |
1.0% |
|
| Weight Decreased |
13.3% |
| Weight Increased |
11.5% |
| Vomiting |
9.7% |
| Blood Glucose Increased |
9.1% |
| Myocardial Infarction |
7.9% |
| Drug Ineffective |
6.3% |
| Flushing |
5.6% |
| Nausea |
4.3% |
| Pruritus |
4.2% |
| Type 2 Diabetes Mellitus |
3.7% |
| Injection Site Pain |
2.9% |
| Pain |
2.9% |
| Visual Impairment |
2.6% |
| Tremor |
2.4% |
| Urinary Tract Infection |
2.4% |
| Vision Blurred |
2.4% |
| Cardiac Failure Congestive |
2.2% |
| Diarrhoea |
2.2% |
| Pancreatitis |
2.2% |
| Paraesthesia |
2.2% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
22.9% |
| Hypertension |
21.0% |
| Diabetes Mellitus |
14.3% |
| Anaemia |
3.8% |
| Blood Pressure Increased |
3.8% |
| Dyslipidaemia |
3.8% |
| Renal Transplant |
3.8% |
| Stress |
3.8% |
| General Physical Condition |
2.9% |
| Gout |
2.9% |
| Irritable Bowel Syndrome |
2.9% |
| Oedema |
2.9% |
| Prophylaxis |
2.9% |
| Seasonal Allergy |
2.9% |
| Cardiac Disorder |
1.9% |
| Arthritis |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Blood Glucose Increased |
1.0% |
| Smoking Cessation Therapy |
1.0% |
|
| Weight Decreased |
44.0% |
| Renal Failure |
12.0% |
| Hypomagnesaemia |
8.0% |
| Malaise |
8.0% |
| Renal Failure Acute |
8.0% |
| Asthenia |
4.0% |
| Bradycardia |
4.0% |
| Drug Interaction |
4.0% |
| Nausea |
4.0% |
| Renal Pain |
4.0% |
|
